ÂÜÀòÂÒÂ×

Elizabeth Adkins Czerepak serves as the Chief Financial Officer of Mirror Biologics, Inc. since April 2024 and has held a consultancy role at Scilex Holding Company since May 2022. Previous leadership positions include CFO, CBO, and EVP at Scilex Holding Company, where Elizabeth played a key role in taking the company public via a SPAC merger. Elizabeth has experience as Chairman of the Audit Committee on the Board of Directors for Delcath Systems, Inc., and has served as CFO, CBO, and EVP at Sorrento Therapeutics, Inc., during its Chapter 11 filing. Other notable positions include acting CFO at BeyondSpring and Chief Financial Officer at Genevant Sciences and Altimmune, Inc., where Elizabeth contributed to the company's public listings and clinical developments. Elizabeth holds a Corporate Director Certificate from Harvard Business School, has FINRA certifications, and possesses an MBA in Finance from Rutgers University - Newark, alongside a Bachelor’s degree from Marshall University.